Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedQuist was a leading provider of medical transcription services and health information management solutions for the healthcare industry. The company specialized in converting dictated medical reports into electronic health records (EHR) using advanced speech recognition and natural language understanding technology. Following its acquisition of MModal in 2011, the company rebranded under the MModal name to focus on clinical documentation and speech-to-text analytics. Its technology assets were eventually acquired by 3M's Health Information Systems division in 2019 to enhance clinical workflow automation. The company's solutions were widely used by major health systems to improve documentation accuracy and physician productivity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedQuist.